RBOT: Vicarious Surgical Inc. Stock

by  •  • Comments Off on RBOT: Vicarious Surgical Inc. Stock

SIC 3842 – Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Valuation
Market Cap ($M) 41.96
Enterprise Value ($M) 3.73
Book Value ($M) 84.01
Book Value / Share 0.57
Price / Book 0.50
NCAV ($M) 65.83
NCAV / Share 0.45
Price / NCAV 0.64

Profitability (mra)
Return on Invested Capital (ROIC) -0.62
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.70

Liquidity (mrq)
Quick Ratio 17.16
Current Ratio 17.16

Balance Sheet (mrq) ($M)
Current Assets 87.11
Assets 105.29
Liabilities 21.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -79.94
Net Income -71.07
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -62.30
Cash from Investing -45.78
Cash from Financing 44.70

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Gates Ventures, Llc 11.70 79.24
08-15 13G/A Sun Hung Kai & Co Ltd 4.10 17.65
08-09 13D/A Khosla Ventures V, L.P. 19.00 38.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ T
2024-04-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P
2024-03-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-14 122,999 431,261 28.52
2024-05-13 66,551 276,342 24.08
2024-05-10 48,068 236,907 20.29
2024-05-09 44,399 214,172 20.73

(click for more detail)

Similar Companies
NVRO – Nevro Corp. NVST – Envista Holdings Corporation
PEN – Penumbra, Inc. RMD – ResMed Inc.
STE – STERIS plc


Financial data and stock pages provided by
Fintel.io